Telix Pharmaceuticals (ASX:TLX) received notice that its Chief Executive Christian Behrenbruch sold 2 million shares in the company at AU$29.50 per share by way of a block trade, according to a Thursday Australian bourse filing.
Behrenbruch now holds shares equal to about 6.3% of the company's issued capital and has no intention to sell them, the filing said.
Additionally, the company's co-founder Andreas Kluge sold 2 million shares in the company for the same price.
Company shares were down nearly 2% in recent Thursday trade.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。